SourceOne Stock Info  Your one source site for stock research




Company Website

Investor Relations



What’s the buzz—

message boards


Market Watch

Money Central

Raging Bull

Board Central









Millennium Pharmaceuticals, Inc.



Millennium Pharmaceuticals, Inc. is biopharmaceutical company focused on discovering, developing and commercializing medicines to change the lives of patients with cancer and inflammatory diseases. It commercializes VELCADE for Injection, for the treatment of patients with multiple myeloma who have received at least one prior therapy. In addition, VELCADE is United States Food and Drug Administration, approved therapeutic for the treatment of patients who have received at least one prior therapy for mantle cell lymphoma, an aggressive form of non-Hodgkin’s lymphoma. Millennium has a development pipeline of nine clinical and preclinical product candidates in its therapeutic focus areas of cancer and inflammation, and it has an oncology-focused discovery organization.


Stock Quotes and Other Information





Silicon Investor



Market Watch

Clear Station



SourceOne Message Board


Search for Stocks:

A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z

Alphabetical Listings by Company Name














S&P 100     S&P 500     S&P 400     Dow Jones Industrials     Dow Jones Transportation     Dow Jones Utilities     Dow Jones Composite     Nasdaq 100     Morgan Stanley Hi-Tech 35